[1]JournalofMedicinalChemistry,1993,vol.36,p.1104-1107
[2]BioorganicandMedicinalChemistry,1999,vol.7,p.2767-2773
[1]JournalofMedicinalChemistry,1993,vol.36,p.1104-1107
[1]Forbes;Kennett;Gadre;Ham;Hayward;Martin;Thompson;Wood;Baxter;Glen;Murphy;Stewart;Blackburn[JournalofMedicinalChemistry,1993,vol.36,#8,p.1104-1107]
Title: Blackburn TP, et al. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study. Synapse. 2006 Jun 15;59(8):502-12.
Title: Kennett GA, et al. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist. Br J Pharmacol. 1994 Mar;111(3):797-802.
Title: Theile JW, et al. Role of 5-hydroxytryptamine2C receptors in Ca2+-dependent ethanol potentiation of GABA release onto ventral tegmental area dopamine neurons. J Pharmacol Exp Ther. 2009 May;329(2):625-33.
